Lausanne-based startup Testmate Health has raised USD 6 million of funding to boost the development and commercialization of their at-home rapid test for sexually transmitted infections STI. The investment round was led by RH Capital with participation from notable co-investors including the Zürcher Kantonalbank and New York City-based venture firm The Helm.
